September 21, 2007Nephron Clinical PracticeOpen Access

Cardiac Biomarkers in Haemodialysis Patients: The Prognostic Value of Amino-Terminal Pro-B-Type Natriuretic Peptide and Cardiac Troponin T

View Full Paper

Ask AI

Bookmark

Why the study?

Do elevated NT-proBNP and cTNT predict cardiovascular morbidity and mortality in chronic haemodialysis patients?

Population

Chronic haemodialysis patients

Design

Review

Authors

CSClaudia SommererHeidelberg University EGEvangelos GiannitsisGeneral Cardiology VSVedat SchwengerUniversity of Stuttgart

Discussion

Member takes

Implication

May aid risk stratification in haemodialysis; leaves open whether biomarker-guided interventions improve outcomes.

Structured PICO

Do elevated NT-proBNP and cTNT predict cardiovascular morbidity and mortality in chronic haemodialysis patients?

Population

Chronic haemodialysis patients

Intervention

Measurement of cardiac biomarkers (amino-terminal pro-B-type natriuretic peptide [NT-proBNP] and cardiac troponin T [cTNT])

Outcome

Cardiovascular morbidity and mortalityhard clinical

Elevated NT-proBNP and cTNT in chronic haemodialysis patients without cardiac ischemia are prognostic for cardiovascular morbidity and mortality and can guide volume control.

Cite This Study

Sommerer et al. (2007) studied this question.

synapsesocial.com/papers/6a70ff9026a7f98052dd6f7f https://doi.org/10.1159/000108647

View Full Paper

Ask AI

Bookmark

Cardiac Biomarkers in Haemodialysis Patients: The Prognostic Value of Amino-Terminal Pro-B-Type Natriuretic Peptide and Cardiac Troponin T

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Cardiac Biomarkers in Haemodialysis Patients: The Prognostic Value of Amino-Terminal Pro-B-Type Natriuretic Peptide and Cardiac Troponin T

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Also Consider